Aniara Diagnostica is pleased to announce the availability of Recombinant Hirudin, a thrombin inhibitor.
WEST CHESTER, OHIO (PRWEB) NOVEMBER 12, 2019
Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
Recombinant Hirudin is a Thrombin inhibitor, which can be used in any in vitro laboratory research application where an efficient inhibition of Thrombin is required.
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
The entire Aniara line is available for purchase at http://www.aniara.com.